Pediatrix Medical Group (NYSE:MD) Raised to "Strong-Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Pediatrix Medical Group to “strong-buy” from “buy,” although the broader analyst consensus remains “hold,” with an average price target of $26.60.
• Pediatrix shares opened at $26.81, up 0.3%, near their 12-month high of $27.94; the company has a $2.18 billion market capitalization and a P/E ratio of 12.83.
• The company exceeded quarterly expectations, reporting $0.63 EPS versus the $0.59 consensus and revenue of $487.78 million, up 4.1% year over year.

Pediatrix Medical Group (NYSE:MD - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report issued on Sunday, Wall Street Zen reports.

A number of other research firms have also recently issued reports on MD. Jefferies Financial Group cut Pediatrix Medical Group from a "buy" rating to a "hold" rating and lifted their price target for the company from $27.00 to $28.00 in a report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $25.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. UBS Group lifted their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a "neutral" rating in a research note on Thursday, August 6th. Weiss Ratings upgraded Pediatrix Medical Group from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday. Finally, Truist Financial increased their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $26.60.

Pediatrix Medical Group Trading Up 0.3%

NYSE MD opened at $26.81 on Friday. The company's fifty day moving average price is $26.42 and its two-hundred day moving average price is $23.59. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. Pediatrix Medical Group has a 12 month low of $15.69 and a 12 month high of $27.94. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of 12.83 and a beta of 0.64.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The business had revenue of $487.78 million during the quarter, compared to analysts' expectations of $478.49 million. During the same quarter in the previous year, the firm earned $0.53 EPS. The firm's revenue was up 4.1% compared to the same quarter last year. As a group, research analysts predict that Pediatrix Medical Group will post 2.17 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of institutional investors and hedge funds have recently modified their holdings of the company. Global Retirement Partners LLC boosted its stake in shares of Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company's stock valued at $29,000 after buying an additional 1,365 shares during the period. Transamerica Financial Advisors LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $30,000. Eurizon Capital SGR S.p.A. acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $33,000. Nykredit A S bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at $35,000. Finally, TD Private Client Wealth LLC acquired a new stake in shares of Pediatrix Medical Group during the 4th quarter worth $39,000. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc is a physician-led healthcare services company that provides specialized medical care for women, infants and children. The company partners with hospitals and health systems to deliver care through physician practices, neonatal intensive care units and other hospital-based programs.

Its services include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric hospital medicine and other pediatric subspecialties. Pediatrix physicians care for patients before, during and after childbirth, as well as children requiring specialized or critical care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.